Influenza vaccination
Influenza vaccination is the administration of an influenza vaccine to induce protective adaptive immunity against circulating influenza viruses. vaccination exposes the immune system to influenza antigens, promoting antigen-specific B- and T-cell responses and the development of antibodies that can reduce the likelihood or severity of subsequent infection.
Influenza vaccination is the administration of an influenza vaccine to induce protective adaptive immunity against circulating influenza viruses. vaccination exposes the immune system to influenza antigens, promoting antigen-specific B- and T-cell responses and the development of antibodies that can reduce the likelihood or severity of subsequent infection. Because influenza viruses undergo continual antigenic change, vaccine composition and vaccination recommendations are reviewed seasonally, and protection is evaluated in relation to the strains circulating during a given season.
Influenza vaccination is used as a preventive Therapy rather than as treatment for established influenza infection. Its public-health impact depends on vaccine effectiveness, vaccination coverage, timely uptake, and acceptance among recommended groups, including Children, older adults, adults with Chronic conditions, and people with other Underlying Medical Conditions. Uptake may be influenced by vaccine hesitancy, perceived morbidity, access, and concurrent vaccination practices such as pneumococcal vaccination. Influenza vaccination is also studied in relation to outcomes beyond respiratory infection, including vascular events in populations with diabetes, although associations with such outcomes do not by themselves establish a direct mechanism or causality.
Where the papers sit
13 papers from the last 6 months study influenza vaccination directly · updated from PubMed 16 Nov 2026
Study type 0 clinical trials · 6 observational · 7 human data
Themes 3 themes · 1 new direction
-
Seasonal Vaccination Coverage and Response
Seasonal influenza vaccination remains tied to uneven coverage, appropriateness, and acceptance across age groups, healthcare workers, and Europe. Effectiveness is examined in children with underlying conditions, while antibody studies connect age and sex differences to estrogenic upregulation of NF-κB and TNF signaling. Surveys and experiments address myths and fear of adverse reactions, and surveillance protocols seek better uptake measurement. European and Italian analyses emphasize gaps between recommendations and delivered vaccination, without a single consistent remedy.
6 papers · 46.2%
-
Influenza Vaccination Outcomes and Uptake
Influenza vaccination is being evaluated both as prevention of severe disease and as a population-uptake challenge. Observational studies focus on hospitalized adults aged 65 years or older and suggest associations with less severe outcomes, including lower incident ischemic stroke among older adults with diabetes. Uptake work tracks people living with HIV and adult coverage in real time, while willingness-to-pay analyses probe barriers among older Vietnamese adults. The evidence is largely population-based and associative, leaving causal effectiveness and equitable delivery open.
5 papers · 38.5%
-
Influenza Vaccine Messaging
Reminder messages and behavioral framing are being tested as practical ways to increase influenza vaccination. Centralized text recall targets pediatric vaccination, while experiments vary vaccine price, individual versus collective-benefit messages, and value orientations. The recurring question is whether low-cost prompts and tailored communication can shift intentions or completed vaccination. Evidence remains focused on behavioral design rather than clinical vaccine performance.
2 papers · 15.4%
Influenza vaccination is presented as a possible preventive measure against ischemic stroke in older adults with diabetes
The population-based retrospective cohort of older adults with diabetes examined first-ever ischemic stroke rather than influenza infection or its immediate complications. In 131,045 adults aged 60 years or older, receipt of the 2021/22 influenza vaccine was associated with a lower risk of incident ischemic stroke after adjustment, with pneumococcal vaccination used as a negative control. This extends influenza vaccination into a potential vascular-stroke-prevention role beyond the set's usual focus on influenza outcomes, vaccination uptake, and delivery. 42522413Jul
Papers
The 13 papers from the last 6 months that study influenza vaccination directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Seasonal Vaccination Coverage and Response (6)
- Influenza vaccination effectiveness in children with underlying medical conditions: a case-control study. European journal of pediatrics · 27 Oct 2026 PMID 42944943
- Enrollment in participatory surveillance programs and influenza vaccination uptake: A systematic review protocol. PloS one · 8 Oct 2026 PMID 42848800
- Coverage and appropriateness of influenza vaccination in adults ≥ 60 y: Provider contribution and adherence to Italian national recommendations. Human vaccines & immunotherapeutics · 25 Sept 2026 PMID 42788870
- Seasonal influenza vaccination coverage and population health burden in Europe during the 2019/2020 and 2021/2022 influenza seasons: an ecological panel analysis using principal-component-adjusted multivariable regression. Vaccine · 18 Sept 2026 PMID 42759249
- Sex and age differences in antibody responses to seasonal influenza vaccination are mediated by estrogenic upregulation of NF-κB and TNF signaling in B cells. mBio · 10 Sept 2026 PMID 42720319
- Myth-busting influenza and fear of adverse reactions in healthcare workers: two experimental studies on vaccination intentions. Vaccine · 28 Aug 2026 PMID 42664528
Influenza Vaccination Outcomes and Uptake (5)
- Association between influenza vaccination and severe outcomes in adults aged ≥ 65 years hospitalized with laboratory-confirmed influenza: a retrospective cohort study, I-MOVE hospital network, Europe, 2015/16-2024/25. Expert review of vaccines · 27 Aug 2026 PMID 42657682
- Influenza vaccination uptake among people living with HIV in Melbourne, 2015-2025: a repeated cross-sectional study. Vaccine · 13 Aug 2026 PMID 42594643
- Influenza vaccination associates with reduced risk of incident ischemic stroke among older adults with diabetes: A population-based retrospective cohort study. Human vaccines & immunotherapeutics · 29 Jul 2026 PMID 42522413
- Willingness to pay for influenza vaccination among the elderly in Vietnam: A triple-bounded dichotomous choice analysis of economic and behavioral determinants. Vaccine · 18 Jun 2026 PMID 42314310
- Real-time in-season monitoring of adult influenza vaccination coverage rates in Germany: results from a repeated cross-sectional online survey. Vaccine · 5 Jun 2026 PMID 42247747
Influenza Vaccine Messaging (2)
- Balancing individual risks and collective benefits: Effects of vaccine price, message framing, and value orientations on influenza vaccination in China. Human vaccines & immunotherapeutics · 8 Oct 2026 PMID 42850200
- A Centralized Text Message Recall for Pediatric Influenza Vaccination, New York City, 2017. Journal of public health management and practice : JPHMP · 21 Jul 2026 PMID 42479583
By study type
Observational studies and case reports (6)
- Influenza vaccination effectiveness in children with underlying medical conditions: a case-control study. European journal of pediatrics · 27 Oct 2026 PMID 42944943
- Association between influenza vaccination and severe outcomes in adults aged ≥ 65 years hospitalized with laboratory-confirmed influenza: a retrospective cohort study, I-MOVE hospital network, Europe, 2015/16-2024/25. Expert review of vaccines · 27 Aug 2026 PMID 42657682
- Influenza vaccination uptake among people living with HIV in Melbourne, 2015-2025: a repeated cross-sectional study. Vaccine · 13 Aug 2026 PMID 42594643
- Influenza vaccination associates with reduced risk of incident ischemic stroke among older adults with diabetes: A population-based retrospective cohort study. Human vaccines & immunotherapeutics · 29 Jul 2026 PMID 42522413
- Willingness to pay for influenza vaccination among the elderly in Vietnam: A triple-bounded dichotomous choice analysis of economic and behavioral determinants. Vaccine · 18 Jun 2026 PMID 42314310
- Real-time in-season monitoring of adult influenza vaccination coverage rates in Germany: results from a repeated cross-sectional online survey. Vaccine · 5 Jun 2026 PMID 42247747
Human data, design not indexed (7)
- Balancing individual risks and collective benefits: Effects of vaccine price, message framing, and value orientations on influenza vaccination in China. Human vaccines & immunotherapeutics · 8 Oct 2026 PMID 42850200
- Enrollment in participatory surveillance programs and influenza vaccination uptake: A systematic review protocol. PloS one · 8 Oct 2026 PMID 42848800
- Coverage and appropriateness of influenza vaccination in adults ≥ 60 y: Provider contribution and adherence to Italian national recommendations. Human vaccines & immunotherapeutics · 25 Sept 2026 PMID 42788870
- Seasonal influenza vaccination coverage and population health burden in Europe during the 2019/2020 and 2021/2022 influenza seasons: an ecological panel analysis using principal-component-adjusted multivariable regression. Vaccine · 18 Sept 2026 PMID 42759249
- Sex and age differences in antibody responses to seasonal influenza vaccination are mediated by estrogenic upregulation of NF-κB and TNF signaling in B cells. mBio · 10 Sept 2026 PMID 42720319
- Myth-busting influenza and fear of adverse reactions in healthcare workers: two experimental studies on vaccination intentions. Vaccine · 28 Aug 2026 PMID 42664528
- A Centralized Text Message Recall for Pediatric Influenza Vaccination, New York City, 2017. Journal of public health management and practice : JPHMP · 21 Jul 2026 PMID 42479583
Written from 13 PubMed abstracts, each one listed by PMID above. Published: 2026-08-20. Drafted by language models from published abstracts; not medical advice.